Hims & Hers Health Inc (NYSE:HIMS) currently has a daily average trading volume of 37.17M but it saw 38861820 shares traded in last market. With a market cap of 12.98B USD, the company’s current market price of $58.00 came falling about -5.24 while comparing to the previous closing price of $61.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $72.98 and as low as $13.47.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the TD Cowen which downgraded the stock as “Hold” in its note to investors issued on April 29, 2025, recommending a price target of $30 for it. Morgan Stanley downgraded its recommendation for the stock as a “Equal-Weight” from “Overweight” on February 18, 2025 while assigning a price target range of $42-$60. Citigroup also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $24 and $25.
Over the week, HIMS’s stock price is moving -5.10% down while it is 128.80% when we observe its performance for the past one month. Year-to-date it is 139.87% up and over the past year, the stock is showing an upside performance of 298.08%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0.22 while estimate for next year EPS is 1.04. In next quarter, company is expected to be making quarterly sales of $584.98M as analysts are expecting the sales for current fiscal year at $2.35B and seeing the company making $2.83B in sales next year. Moreover, analysts are in estimates of $549.15M for current-quarter revenue.
Currently, Hims & Hers Health Inc’s total number of outstanding shares is 215.21M with 11.09% of that held by the insiders while 74.34% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 27.00% and return on equity (ROE) at 36.79%. It has a price to earnings ratio (P/E ratio) of 84.43 while having a 60.17 of forward P/E ratio. Stock’s beta reads 2.06. Stock has a price to book (P/B) ratio of 23.61 while price to sale or P/S ratio amounts to 7.28. Its return on asset (ROA) is 24.54% on average.
